Haley Ellis

2.6k total citations
23 papers, 544 citations indexed

About

Haley Ellis is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Haley Ellis has authored 23 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Haley Ellis's work include Pancreatic and Hepatic Oncology Research (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Cancer Genomics and Diagnostics (5 papers). Haley Ellis is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Cancer Genomics and Diagnostics (5 papers). Haley Ellis collaborates with scholars based in United States, United Kingdom and Ireland. Haley Ellis's co-authors include X. Cynthia, Maurizio Scaltriti, Pau Castel, José Baselga, Maura N. Dickler, Edi Brogi, Ružica Bago, Dario R. Alessi, Chandra Verma and Sarat Chandarlapaty and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Cell.

In The Last Decade

Haley Ellis

23 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haley Ellis United States 11 329 181 139 136 72 23 544
Janet I. Lee United States 8 502 1.5× 191 1.1× 104 0.7× 168 1.2× 68 0.9× 8 636
Karen G. Spink United Kingdom 10 392 1.2× 278 1.5× 169 1.2× 177 1.3× 89 1.2× 13 722
Angela Tam United States 9 426 1.3× 115 0.6× 71 0.5× 159 1.2× 48 0.7× 12 634
Jamie Sheren United States 8 313 1.0× 164 0.9× 143 1.0× 282 2.1× 58 0.8× 9 599
Marissa Shrader United States 9 380 1.2× 292 1.6× 158 1.1× 134 1.0× 62 0.9× 15 628
Sally J. York United States 10 321 1.0× 244 1.3× 126 0.9× 150 1.1× 71 1.0× 22 600
S Hoffarth Germany 11 306 0.9× 224 1.2× 109 0.8× 73 0.5× 63 0.9× 12 565
Nolan Priedigkeit United States 13 344 1.0× 256 1.4× 253 1.8× 220 1.6× 58 0.8× 16 665
Yasuhiro Oshimo Japan 6 403 1.2× 201 1.1× 134 1.0× 98 0.7× 88 1.2× 6 607

Countries citing papers authored by Haley Ellis

Since Specialization
Citations

This map shows the geographic impact of Haley Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haley Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haley Ellis more than expected).

Fields of papers citing papers by Haley Ellis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haley Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haley Ellis. The network helps show where Haley Ellis may publish in the future.

Co-authorship network of co-authors of Haley Ellis

This figure shows the co-authorship network connecting the top 25 collaborators of Haley Ellis. A scholar is included among the top collaborators of Haley Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haley Ellis. Haley Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ellis, Haley, Chiara Braconi, Juan W. Valle, & Nabeel Bardeesy. (2024). Cholangiocarcinoma Targeted Therapies. American Journal Of Pathology. 195(3). 437–452. 4 indexed citations
2.
Ellis, Haley & Lipika Goyal. (2024). Are FGFR Fusions and Mutations the Next Tumor-Agnostic Targets in Oncology?. JCO Precision Oncology. 8(8). e2400113–e2400113. 5 indexed citations
3.
Balasooriya, Eranga R., Haley Ellis, Yuanli Zhen, et al.. (2024). The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations. Clinical Cancer Research. 30(10). 2181–2192. 6 indexed citations
4.
Zhen, Yuanli, Kai Liu, Lei Shi, et al.. (2024). FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma. Nature Communications. 15(1). 3805–3805. 10 indexed citations
5.
Ellis, Haley, Giulia Siravegna, Alexa Michel, et al.. (2023). Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma. Clinical Cancer Research. 30(1). 198–208. 38 indexed citations
6.
7.
Quintanilha, Júlia C.F., Ryon P. Graf, Virginia Fisher, et al.. (2023). Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair, or Tumor Mutational Burden. JAMA Network Open. 6(1). e2252244–e2252244. 26 indexed citations
8.
Kato, Hiroyuki, Haley Ellis, & Nabeel Bardeesy. (2023). KRAS Wild-Type Pancreatic Cancer: Decoding Genomics, Unlocking Therapeutic Potential. Clinical Cancer Research. 29(22). 4527–4529. 1 indexed citations
9.
Huffman, Brandon M., Haley Ellis, Alexander C. Jordan, et al.. (2022). Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma. Cancers. 14(24). 6223–6223. 14 indexed citations
10.
Capietto, Aude-Hélène, et al.. (2021). Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets. Cancer Immunology Research. 9(12). 1400–1412. 14 indexed citations
11.
Dang, Ha X., Pradeep S. Chauhan, Haley Ellis, et al.. (2020). Cell-Free DNA Alterations in the AR Enhancer and Locus Predict Resistance to AR-Directed Therapy in Patients With Metastatic Prostate Cancer. JCO Precision Oncology. 4(4). 680–713. 21 indexed citations
12.
Ellis, Haley & X. Cynthia. (2019). PI3K Inhibitors in Breast Cancer Therapy. Current Oncology Reports. 21(12). 110–110. 151 indexed citations
13.
Castel, Pau, Haley Ellis, Ružica Bago, et al.. (2016). PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition. Cancer Cell. 30(2). 229–242. 173 indexed citations
14.
O’Leary, Connor, Haley Ellis, & Michaela J. Higgins. (2016). Extended adjuvant endocrine therapy in hormone-receptor-positive early breast cancer. Current Opinion in Oncology. 28(6). 455–460. 7 indexed citations
15.
Yamamoto, Hirofumi, Norikatsu Miyoshi, Koshi Mimori, et al.. (2014). MACC1 expression levels as a novel prognostic marker for colorectal cancer. Oncology Letters. 8(5). 2305–2309. 11 indexed citations
16.
Ting, David T., Ben S. Wittner, Ajay M. Shah, et al.. (2014). Abstract NG04: Diversity of circulating tumor cells in a mouse pancreatic cancer model identified by single cell RNA sequencing. Cancer Research. 74(19_Supplement). NG04–NG04. 2 indexed citations
17.
18.
Ellis, Haley, et al.. (2010). High-throughput applicable genomic sex typing of chicken by TaqMan real-time quantitative polymerase chain reaction. Poultry Science. 89(7). 1451–1456. 13 indexed citations
19.
Ellis, Haley, et al.. (1980). The local treatment of breast cancer.. PubMed. 224(1348). 1003–8. 2 indexed citations
20.
Ellis, Haley, et al.. (1966). A trial of mithramycin in the treatment of advanced malignant disease.. British Journal of Cancer. 20(2). 256–263. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janet I. Lee Breakdown of academic impact, for papers by Karen G. Spink Breakdown of academic impact, for papers by Angela Tam Breakdown of academic impact, for papers by Jamie Sheren Breakdown of academic impact, for papers by Marissa Shrader Breakdown of academic impact, for papers by Sally J. York Breakdown of academic impact, for papers by S Hoffarth Breakdown of academic impact, for papers by Nolan Priedigkeit Breakdown of academic impact, for papers by Yasuhiro Oshimo
Rankless by CCL
2026